Capala J[au] - Search Results

Year	Number of Results
1990	1
1991	3
1992	1
1994	1
1995	1
1996	4
1997	4
1998	3
1999	3
2000	3
2001	2
2002	1
2003	5
2004	2
2005	5
2006	1
2007	2
2008	7
2009	7
2010	8
2011	6
2012	8
2013	2
2014	8
2015	4
2016	6
2017	2
2018	7
2019	7
2020	5
2021	7

1

Current Status of Radiopharmaceutical Therapy.

St James S, Bednarz B, Benedict S, Buchsbaum JC, Dewaraja Y, Frey E, Hobbs R, Grudzinski J, Roncali E, Sgouros G, Capala J, Xiao Y. St James S, et al. Among authors: capala j. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):891-901. doi: 10.1016/j.ijrobp.2020.08.035. Epub 2020 Aug 14. Int J Radiat Oncol Biol Phys. 2021. PMID: 32805300 Review.

2

Clinical Outcome Assessments Toolbox for Radiopharmaceuticals.

Kunos CA, Capala J, Dicker AP, Movsas B, Ivy SP, Minasian LM. Kunos CA, et al. Among authors: capala j. Front Oncol. 2019 Oct 10;9:1028. doi: 10.3389/fonc.2019.01028. eCollection 2019. Front Oncol. 2019. PMID: 31649885 Free PMC article.

3

Phase 0 Radiopharmaceutical-Agent Clinical Development.

Kunos CA, Rubinstein LV, Capala J, McDonald MA. Kunos CA, et al. Among authors: capala j. Front Oncol. 2020 Aug 18;10:1310. doi: 10.3389/fonc.2020.01310. eCollection 2020. Front Oncol. 2020. PMID: 33014772 Free PMC article.

4

Radiopharmaceuticals for Relapsed or Refractory Leukemias.

Kunos CA, Capala J, Ivy SP. Kunos CA, et al. Among authors: capala j. Front Oncol. 2019 Feb 25;9:97. doi: 10.3389/fonc.2019.00097. eCollection 2019. Front Oncol. 2019. PMID: 30859091 Free PMC article.

5

Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers.

Kunos CA, Capala J, Finnigan S, Smith GL, Ivy SP. Kunos CA, et al. Among authors: capala j. Front Oncol. 2019 Mar 26;9:180. doi: 10.3389/fonc.2019.00180. eCollection 2019. Front Oncol. 2019. PMID: 30984615 Free PMC article.

6

Radiopharmaceutical Switch Maintenance for Relapsed Ovarian Carcinoma.

Kunos CA, Capala J. Kunos CA, et al. Among authors: capala j. Pharmaceuticals (Basel). 2020 Sep 30;13(10):287. doi: 10.3390/ph13100287. Pharmaceuticals (Basel). 2020. PMID: 33008086 Free PMC article.

7

Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer.

Kunos CA, Capala J, Kohn EC, Ivy SP. Kunos CA, et al. Among authors: capala j. Front Oncol. 2019 Jun 26;9:560. doi: 10.3389/fonc.2019.00560. eCollection 2019. Front Oncol. 2019. PMID: 31297338 Free PMC article.

8

National Cancer Institute Programmatic Collaboration for Investigational Radiopharmaceuticals.

Kunos CA, Capala J. Kunos CA, et al. Among authors: capala j. Am Soc Clin Oncol Educ Book. 2018 May 23;38:488-494. doi: 10.1200/EDBK_200199. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231365 Free article. Review.

9

A New Generation of "Magic Bullets" for Molecular Targeting of Cancer.

Capala J, Kunos CA. Capala J, et al. Clin Cancer Res. 2021 Jan 15;27(2):377-379. doi: 10.1158/1078-0432.CCR-20-3690. Epub 2020 Nov 3. Clin Cancer Res. 2021. PMID: 33144340

10

Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master Files.

Kunos CA, Capala J, Ivy SP. Kunos CA, et al. Among authors: capala j. Front Oncol. 2019 Jun 28;9:573. doi: 10.3389/fonc.2019.00573. eCollection 2019. Front Oncol. 2019. PMID: 31316916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results